Inhaled sodium metabisulphite (MBS) causes bronchoconstriction, cough and microvascular leakage. We have studied its effects on tracheal blood flow, potential difference (PD) and the permeability from tracheal lumen to venous blood of a low molecular weight hydrophilic tracer, 99m technetium-labelled diethylenetriamine penta-acetic acid ( 99m Tc-DTPA) in anaesthetized sheep.Flow was measured in a tracheal artery and blood from a cannulated tracheal vein collected for 5 min periods. The tracheal lumen was filled with Krebs-Henseleit solution (KH) containing 99m Tc-DTPA for six to eight 15 min periods. During the third or fourth period, MBS (1, 20 or 100 mM) was washed into the tracheal lumen for 15 min.MBS increased tracheal blood flow (venous flow (Q'v), 5-10 min MBS exposure period: 1 mM -9±18% (n=3); 20 mM +16±5% (n=5; p<0.05); 100 mM + 43±13% (n=5; p<0.05). It decreased PD in a concentration-dependent way. Venous 99m Tc-DTPA concentration increased progressively to +266±176 and + 958±321% 25-30 min after exposure to 20 and 100 mM MBS, respectively (p<0.05 for both). These effects were not blocked by luminal frusemide (3-7 mM) or flurbiprofen (100-500 µM). Histological sections showed changes to the epithelial cells and large intercellular spaces.Thus, luminal sodium metabisulphite increases tracheal blood flow, reduces transmural potential difference and causes tracheal epithelial damage, leading to an increase in 99m Tc-labelled diethylenetriamine penta-acetic acid permeability. Eur Respir J., 1996, 9, 976- Sodium metabisulphite (MBS) is a widely-used food preservative which, when ingested, causes bronchoconstriction in some asthmatics [1]. On inhalation it causes bronchoconstriction in man -asthmatics, atopics [2], and normals [3] -and also in animals [4,5].The mechanism of MBS-induced bronchoconstriction is still uncertain. In solution it forms the bisulphite ion and SO 2 [6]. Some [7], but not all [4,8], studies in man have shown that the bronchoconstriction is blocked by muscarinic antagonists. Its effect is also inhibited by drugs that inhibit sensory nerves, e.g. nedocromil sodium [9,10] and cromoglycate [9], and in the guinea-pig its action is reduced by capsaicin pretreatment [4] and inhibited by neurokinin 1 and 2 (NK 1 and NK 2 ) receptor antagonists [11], suggesting the involvement of tachykinins released from sensory nerve endings.MBS-induced bronchoconstriction is also blocked by frusemide [12,13]. Frusemide is effective against a variety of other indirectly acting bronchoconstrictor stimuli, including distilled water aerosols [14], exercise [15] and allergen [16]. The mechanism appears to be unrelated to its diuretic action. The airway effects could be due to the release of the bronchodilator prostaglandin E 2 (PGE 2 ) [17]. However, more recent evidence has shown that flurbiprofen, a cyclo-oxygenase inhibitor, partly blocks the effects of MBS on bronchoconstriction and also enhances the effect of frusemide [18]. This implies that MBS may cause the release of bronchoconstrictor prosta...